Lynx1 Capital Management LP - 30 Sep 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: LYNX1 CAPITAL MANAGEMENT LP
Security: Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: CGEM
Shares outstanding: 58,837,653 shares
Disclosed Ownership: 5,766,090 shares
Ownership: 9.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 14:00:43 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Aug 2025
Next filing: 10 Oct 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
LYNX1 CAPITAL MANAGEMENT LP	9.8%	5,766,090	0	5,766,090	s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
WESTON NICHOLS	9.8%	5,766,090	0	5,766,090	/s/ Weston Nichols	Weston Nichols, Individually